Clinical Trial Update: Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the efficacy and safety of ICP-332 versus placebo in adults with moderate to severe plaque psoriasis; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ICP-332

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Plaque Psoriasis | Phase 2 | Status: RECRUITING